NEW YORK, Nov. 5, 2015 /PRNewswire/ -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who purchased Sientra, Inc. (NASDAQGS: SIEN) securities between March 18, 2015 and September 24, 2015.
Click here to learn about the case: http://docs.wongesq.com/SIEN-Info-Request-Form-963. There is no cost or obligation to you.
The complaint alleges that defendants failed to disclose that Sientra's exclusive reliance on Silimed's Brazilian manufacturing facilities carried significant quality control risks and that the manufacturing processes at the Silimed Rio de Janeiro manufacturing plant were contaminated. On March 18, 2015, Sientra filed its Form 10-K with the U.S. Securities and Exchange Commission, which stated that it was primarily responsible for the manufacturing and quality assurance of its products.
On September 24, 2015, the United Kingdom's Medicines and Healthcare Products Regulatory Agency suspended sales of Silimed products after an audit of Silimed's manufacturing processes revealed contamination in the manufacturing plant. On this news, Sientra stock fell $10.88, or nearly 52.9%, to close at $9.70 per share on September 24, 2015.
If you suffered a loss in Sientra you have until November 24, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email email@example.com, by telephone at 212.425.1140, or visit http://docs.wongesq.com/SIEN-Info-Request-Form-963.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
Vincent Wong, Esq.
39 East Broadway
New York, NY 10002
SOURCE The Law Offices of Vincent Wong